1932

Abstract

▪ Abstract 

Cholesterol and its metabolites play a variety of essential roles in living systems. Virtually all animal cells require cholesterol, which they acquire through synthesis or uptake, but only the liver can degrade cholesterol. The gene product regulates the rate-controlling step in the removal of cellular cholesterol: the efflux of cellular cholesterol and phospholipids to an apolipoprotein acceptor. Mutations in , as seen in Tangier disease, result in accumulation of cellular cholesterol, reduced plasma high-density lipoprotein cholesterol, and increased risk for coronary artery disease. To date, more than 100 coding variants have been identified in , and these variants result in a broad spectrum of biochemical and clinical phenotypes. Here we review genetic variation in and its critical role in cholesterol metabolism and atherosclerosis in the general population.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.nutr.26.061505.111214
2006-08-21
2024-04-19
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.nutr.26.061505.111214
Loading
/content/journals/10.1146/annurev.nutr.26.061505.111214
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error